×

  • Mylan Pharmaceuticals Incorporated et al v. Sanofi-Aventis Deutschland GmbH IPR of '844 PTAB CAFC

    • IPR2018-01680
    • 3700
    • Judge: Bart A. Gerstenblith +5
    • Filed: 09/10/2018
    • Institution: 04/03/2019
    • Final: 05/29/2020
    • Latest Docket Entry: 08/10/2022
    • PTAB
    • Administrative Judges
    • Bart A. Gerstenblith
    • Hyun J. Jung
    • Jacqueline W. Bonilla
    • James A. Tartal
    • James Joseph Mayberry
2
Petitioners
1
Patent Owner
1
Challenged Patent

  • Mylan Pharmaceuticals Incorporated et al v. Sanofi-Aventis Deutschland GmbH IPR of '844 PTAB CAFC

    • IPR2018-01680
    • 3700
    • Judge: Bart A. Gerstenblith +5
    • Filed: 09/10/2018
    • Institution: 04/03/2019
    • Final: 05/29/2020
    • Latest Docket Entry: 08/10/2022
    • PTAB
    • Administrative Judges
    • Bart A. Gerstenblith
    • Hyun J. Jung
    • Jacqueline W. Bonilla
    • James A. Tartal
    • James Joseph Mayberry
PTAB Petition | Rpx Insight
View Petition
Appeals
20-2066
20-2068
Joinder
IPR2019-01022 joined this IPR
Final Decision
All Claims Unpatentable
Cause of Action
Inter Partes Review
Administrative Judges
Bart A. Gerstenblith
Hyun J. Jung
Jacqueline W. Bonilla
James A. Tartal
James Joseph Mayberry
  • Patent Information
×
×